Netskope, Inc. Class A Common Stock (NASDAQ:NTSK) Q4 2026 Earnings Call Transcript March 11, 2026 Netskope, Inc. Class A Common Stock misses on earnings expectations. Reported EPS is $-0.14388 EPS, ...

For many students, math carries a reputation that makes palms sweat before a single number appears on the board. Pi Day flips that script on ... Read moreThe post On ...

Peter Sack - Co-CEO, Principal Executive Officer, & Director of Chicago Atlantic REIT Manager, LLC David Kite - Chief Operating Officer of Chicago Atlantic REIT Manager, LLC Good day, and welcome to ...

The Touchstone Large Cap Fund (Class A Shares, Load Waived) underperformed its benchmark, the Russell 1000® Index, for the quarter ended December 31, 2025. Read more here.

Recent news coverage of tourism worldwide has shown how prioritizing uncontrolled economic growth results in unsustainable visitor numbers in many destinations. Tourism as a development strategy often ...

The board declared a $0.30 per share dividend for the following quarter, to be paid Apr. 15, 2026, to shareholders of record as of Mar. 31, 2026. Portfolio yield -- Portfolio (excluding Thompson Hotel ...

ORLANDO, Fla., March 12, 2026 (GLOBE NEWSWIRE)-- Abacus Global Management, Inc. ("Abacus" or the "Company") (NYSE: ABX), a leader in the alternative asset management industry, today reported results ...

Earnings call Yduqs reported over BRL 1 billion in net cash flow (pre-interest), a 38% YoY increase in free cash flow to equity, and a group margin above 25% for 2025. Premium segments (Ibmec, IDOMED) ...

CCC’s director of solutions delivery shares what collision repair professionals are asking him— and what they should be doing about it.

Fossil Group, Inc. (NASDAQ:FOSL) Q4 2025 Earnings Call Transcript March 11, 2026 Fossil Group, Inc. misses on earnings expectations. Reported EPS is $ EPS, expectations were $0.02. Operator: Good ...

Detailed price information for Atea Pharmaceuticals Inc (AVIR-Q) from The Globe and Mail including charting and trades.

My journey has been a long one. I am a paediatric immunologist and principal investigator of a PID research laboratory, and ...